Skip to main content

Mechanisms of Adverse Reactions in the Skin from Anti-Rheumatic Drugs

  • Chapter
Book cover Side Effects of Anti-Inflammatory Drugs IV

Abstract

Various rash conditions ranging in pathology and severity occur frequently with NSAIDs and some other anti-rheumatic drugs. Known collectively as dermatitis medicamentosa or ‘drug eruptions’, they manifest as erythema, urticaria, morbilliform eruptions, purpura, lichen planus and photo-sensitivity reactions to the severe bullouslike as well as the often fatal Stevens—Johnson and Lyell’s syndromes (Table 1) [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stern RS, Bigby M. An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a speciality-based system for spontaneous reporting of adverse reactions to drugs. J Am Med Assoc. 1984;252:1433–7.

    Article  CAS  Google Scholar 

  2. Bork K. Cutaneous Side-Effects of Drugs. Philadelphia: WB Saunders; 1988.

    Google Scholar 

  3. Rainsford KD. Mechanisms of rash formation and related skin conditions induced by non-steroidal anti-inflammatory drugs. In: Rainsford KD, Velo GP, eds. Side-Effects of Anti-Inflammatory Drugs, vol. 3. Lancaster: Kluwer Academic Publishers; 1992:287–301.

    Chapter  Google Scholar 

  4. Penso D, Roujeau JC, Guillaume JC, Revuz J, Touraine R. Toxic epidermal necrolysis after oxicam use. J Am Dermatol. 1986;14:275–6.

    Article  CAS  Google Scholar 

  5. Stern RS. Phototoxic reactions to piroxicam and other nonsteroidal antiinflammatory agents. N Engl J Med. 1983;309:186–7.

    PubMed  CAS  Google Scholar 

  6. Kochevar IE, Morison WL, Lamm JL, McAuliffe DJ, Western A, Hood AF. Possible mechanism of piroxicam-induced photosensitivity. Arch Dermatol. 1986;122:1283–7.

    Article  PubMed  CAS  Google Scholar 

  7. Hort JF. Adverse reactions to alclofenac. Curr Med Res Opin. 1976;3:333–7.

    Article  Google Scholar 

  8. Parke AL, Ioannides C, Lewis DFV, Parke DV. Molecular pathology of drug-disease interactions in chronic autoimmune inflammatory diseases. Inflammopharmacology. 1991;1:3–36.

    Article  CAS  Google Scholar 

  9. Muhktak H, Agareval R, Bickers DR. Cutaneous metabolism of xenobiotics and steroid hormones. In: Muhktah H, ed. Pharmacology of the Skin. Boca Raton: CRC Press; 1992:89–109.

    Google Scholar 

  10. Muhktah H. Cutaneous cytochrome P-450. In: Muhktah H, ed. Pharmacology of the Skin. Boca Raton: CRC Press; 1992:139–47.

    Google Scholar 

  11. Schwarz T, Liger TA. Pharmacology of cytokines in the skin. In: Muhktah H, ed. Pharmacology of the Skin. Boca Raton: CRC Press; 1992:283–313.

    Google Scholar 

  12. Jandl RC, George JL, Dinarello Ca, Schur PH. The effect of interleukin 1 on IgG synthesis in systemic lupus erythematosus. Clin Immunol Immunopathol. 1987;45:384–94.

    Article  PubMed  CAS  Google Scholar 

  13. Hauser C, Saurat J-H, Schmitt A, Jaunin F, Dayer J-M. Interleukin 1 is present in normal human epidermis. J Immunol. 1986;136:3317–21.

    PubMed  CAS  Google Scholar 

  14. Mizutani H, Black R, Kuppers TS. Human keratinocytes produce but not process pro-interleukin 1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest. 1991;87:1966–71.

    Article  Google Scholar 

  15. Groves RW, Rauschmayr T, Nakamura K, Sarkar S, Williams IR, Kupper TS. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type 1) on epidermal keratinocytes. Evidence that IL-1 inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest. 1996;98:336–44.

    Article  PubMed  CAS  Google Scholar 

  16. Lange-Wantzin G, Rothlein R, Khan J, Faanes RB. Effect of UV irradiation on expression of membrane IL-1 by rat macrophages. J Immunol. 1987;138:3803–7.

    PubMed  CAS  Google Scholar 

  17. Hopkins SJ, Holt I, Humphreys M. Removal of inhibitory activity and determination of biologically active interleukin-1 in biological fluids. In: Dinarello CA, Kluger MJ, Powanda MC, Oppenheim JJ, eds. The Physiology and Pathological Effects of Cytokines. New York: Wiley-Liss; 1990:7–12.

    Google Scholar 

  18. Rainsford KD, Ying C, Smith F. Effects of 5-lipoxygenase inhibitors on interleukin production by human synovial tissues in organ culture: comparison with interleukin-1 synthesis inhibitors. J Pharm Pharmacol. 1996;48:45–50.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Rainsford, K.D. (1997). Mechanisms of Adverse Reactions in the Skin from Anti-Rheumatic Drugs. In: Rainsford, K.D. (eds) Side Effects of Anti-Inflammatory Drugs IV. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5394-2_31

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5394-2_31

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6269-5

  • Online ISBN: 978-94-011-5394-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics